Physician profile
Thai Vu
NPI 1841727013
$436.03
in general payments reported to CMS, 2019-2025
8 companies · $325 in 2025
The $325 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $47.72 · 2024: $63.62 · 2025: $325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $363 · Education: $24.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.38 |
| Education | $24.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $113.07 | 2025 | Intracept |
| Abbott Laboratories | $103.34 | 2025 | Octrode, Proclaim |
| Nalu Medical, INC. | $59.04 | 2025 | Nalu Neurostimulation System |
| Arteriocyte Medical Systems, INC. | $49.24 | 2025 | Magellan |
| Medtronic, INC. | $38.69 | 2024 | Kyphon Express II Kyphopak Tray |
| Stratus Medical, LLC | $29.78 | 2022 | |
| Otto Bock Healthcare Lp | $24.93 | 2024 | |
| Bioventus LLC | $17.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thai Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.